FindMyRecallSubscribe
Class II: temporary or reversible health riskTerminated

Jubilant Cadista Pharmaceuticals clomiPRAMINE Hydrochloride Capsules Recall

clomiPRAMINE Hydrochloride Capsules USP, 50 mg, 30-count bottle, Rx Only, Manufactured…

Jubilant Cadista Pharmaceuticals, Inc. · Salisbury, MD

Risk level
Class II
Reported by FDA
Dec 2, 2020
Recall ID
D-0104-2021
Check your lot numberHow we source this data

Summary

Jubilant Cadista Pharmaceuticals recalled clomiPRAMINE Hydrochloride Capsules starting Nov 6, 2020. The FDA classified it as Class II (temporary or reversible health risk) and published enforcement report D-0104-2021 on Dec 2, 2020. Reason: Failed Tablet/Capsule Specification. Status: Terminated.

Why it was recalled

Failed Tablet/Capsule Specification

Product description

clomiPRAMINE Hydrochloride Capsules USP, 50 mg, 30-count bottle, Rx Only, Manufactured by: Jubilant Cadista Pharmaceuticals Inc., Salisbury, MD NDC 59746-711-30

Lot numbers, UPCs & expiration codes

Lot# 20P0141, exp. date 02/2022

Where it was sold

Product was distributed nationwide.

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-0104-2021
Classification
Class II
Status
Terminated
Recall initiated
Nov 6, 2020
FDA report date
Dec 2, 2020
Quantity
4,416 bottles
Recall type
Voluntary: Firm initiated
Recalling firm
Jubilant Cadista Pharmaceuticals, Inc.

Original FDA data

Every field from FDA enforcement report D-0104-2021, exactly as published.

Show all FDA fields
City
Salisbury
State
MD
Status
Terminated
Country
United States
Event ID
86698
Address
207 Kiley Dr
Code information
Lot# 20P0141, exp. date 02/2022
Postal code
21801-2249
Report date
Dec 2, 2020
Product type
Drugs
Recall number
D-0104-2021
Classification
Class II
Recalling firm
Jubilant Cadista Pharmaceuticals, Inc.
Product quantity
4,416 bottles
Termination date
Mar 23, 2022
Reason for recall
Failed Tablet/Capsule Specification
Voluntary / mandated
Voluntary: Firm initiated
Product description
clomiPRAMINE Hydrochloride Capsules USP, 50 mg, 30-count bottle, Rx Only, Manufactured by: Jubilant Cadista Pharmaceuticals Inc., Salisbury, MD NDC 59746-711-30
Distribution pattern
Product was distributed nationwide.
Recall initiation date
Nov 6, 2020
Initial firm notification
Letter
Center classification date
Nov 24, 2020

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-0104-2021, published Dec 2, 2020. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls